Sánchez-Barceló EJ - Search Results

1

Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.

Cos S, González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ. Cos S, et al. Cancer Detect Prev. 2006;30(2):118-28. doi: 10.1016/j.cdp.2006.03.002. Epub 2006 May 2. Cancer Detect Prev. 2006. PMID: 16647824 Review.

2

Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?

Cos S, Mediavilla MD, Fernández R, González-Lamuño D, Sánchez-Barceló EJ. Cos S, et al. J Pineal Res. 2002 Mar;32(2):90-6. doi: 10.1034/j.1600-079x.2002.1821.x. J Pineal Res. 2002. PMID: 12071473

3

Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.

Cos S, Martínez-Campa C, Mediavilla MD, Sánchez-Barceló EJ. Cos S, et al. J Pineal Res. 2005 Mar;38(2):136-42. doi: 10.1111/j.1600-079X.2004.00186.x. J Pineal Res. 2005. PMID: 15683469

4

Melatonin-estrogen interactions in breast cancer.

Sánchez-Barceló EJ, Cos S, Mediavilla D, Martínez-Campa C, González A, Alonso-González C. Sánchez-Barceló EJ, et al. J Pineal Res. 2005 May;38(4):217-22. doi: 10.1111/j.1600-079X.2004.00207.x. J Pineal Res. 2005. PMID: 15813897 Review.

5

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats.

Cos S, Mediavilla D, Martínez-Campa C, González A, Alonso-González C, Sánchez-Barceló EJ. Cos S, et al. Cancer Lett. 2006 Apr 28;235(2):266-71. doi: 10.1016/j.canlet.2005.04.025. Epub 2005 Jun 13. Cancer Lett. 2006. PMID: 15950374

6

Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.

Cos S, González A, Güezmes A, Mediavilla MD, Martínez-Campa C, Alonso-González C, Sánchez-Barceló EJ. Cos S, et al. Int J Cancer. 2006 Jan 15;118(2):274-8. doi: 10.1002/ijc.21401. Int J Cancer. 2006. PMID: 16080194

7

Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells.

Martínez-Campa C, González A, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ, Cos S. Martínez-Campa C, et al. Breast Cancer Res Treat. 2005 Dec;94(3):249-54. doi: 10.1007/s10549-005-9006-x. Epub 2005 Oct 22. Breast Cancer Res Treat. 2005. PMID: 16244789

8

Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells.

Martínez-Campa CM, Alonso-González C, Mediavilla MD, Cos S, González A, Sanchez-Barcelo EJ. Martínez-Campa CM, et al. Cancer Lett. 2008 Sep 18;268(2):272-7. doi: 10.1016/j.canlet.2008.04.001. Epub 2008 May 13. Cancer Lett. 2008. PMID: 18479810

9

In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.

González A, Alvarez-García V, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ, Cos S. González A, et al. Curr Cancer Drug Targets. 2010 May;10(3):279-86. doi: 10.2174/156800910791190201. Curr Cancer Drug Targets. 2010. PMID: 20370689

10

Breast cancer therapy based on melatonin.

Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, Rueda N. Sanchez-Barcelo EJ, et al. Recent Pat Endocr Metab Immune Drug Discov. 2012 May;6(2):108-16. doi: 10.2174/187221412800604581. Recent Pat Endocr Metab Immune Drug Discov. 2012. PMID: 22369716 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters